Literature DB >> 7907819

IL-12 holds promise against cancer, glimmer of AIDS hope.

S S Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907819     DOI: 10.1126/science.7907819

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections.

Authors:  Bingyun Li; Bingbing Jiang; Brandon M Boyce; Brock A Lindsey
Journal:  Biomaterials       Date:  2009-02-12       Impact factor: 12.479

Review 2.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.

Authors:  G Vanham; L Penne; J Devalck; L Kestens; R Colebunders; E Bosmans; K Thielemans; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

4.  Targeted Delivery of IL-12 Adjuvants Immunotherapy by Oncolytic Viruses.

Authors:  Andrea Vannini; Valerio Leoni; Gabriella Campadelli-Fiume
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.

Authors:  A M Cooper; A D Roberts; E R Rhoades; J E Callahan; D M Getzy; I M Orme
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

6.  Altered IL-10 levels in trauma patients' M phi and T lymphocytes.

Authors:  C L Miller-Graziano; A K De; K Kodys
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.